Drug Topics

NOVEMBER 11, 2022

Collecting data on social determinants of health carries a number of issues and needs to be improved to create learning health systems.

189

189

Pharmacy Times

NOVEMBER 11, 2022

Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.

Vaccines 123

Vaccines 123

Drug Topics

NOVEMBER 11, 2022

CBD therapy has had positive outcomes in other inflammatory conditions.

227

227

Pharmacy Times

NOVEMBER 11, 2022

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.

Vaccines 123

Vaccines 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

NOVEMBER 11, 2022

Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, share thoughts on COVID-19 vaccines and boosters in anticipation of an uptick in cases in the coming months.

Vaccines 112

Vaccines 112

Pharmacy Times

NOVEMBER 11, 2022

This Veteran’s Day, NCPA CEO B. Douglas Hoey, PharmD, MBA, discusses the implications of Express Scripts’ elimination of the pharmacy of choice option for Tricare beneficiaries in their contract with the Department of Defense.

122

122

Pharmacy Times

NOVEMBER 11, 2022

Analysis indicates that a 25-mg dose reduces the condition scores significantly more than a 1mg dose over a 3-week period, but the 10-mg dose did not yield the same results.

122

122

The Checkup by Singlecare

NOVEMBER 11, 2022

More than 37 million people in the United States, or 11.3% of the population, are living with diabetes, according to the American Diabetes Association. Some of them are turning to complementary and alternative medicine for treatment or wellness purposes—or both. In fact, a 2017 study in the Journal of Diabetes found that 26.2% of adults with diabetes reported giving complementary medicine a try. .

116

116

Pharmacy Times

NOVEMBER 11, 2022

States with a higher prevalence of Medicaid patients with type 2 diabetes were found to have lower use ratio of glucose-lowering agents with known cardiovascular benefits.

123

123

Drug Topics

NOVEMBER 11, 2022

ADHD is an all-day affair, and treating it in an adult population can be difficult.

138

138

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

NOVEMBER 11, 2022

New continuous glucose monitor systems provide additional support and quality of life improvements for patients with diabetes.

132

132

STAT

NOVEMBER 11, 2022

There is no place for violence in civil society. Yet stabbings, shootings, threats and other violent attacks have become frighteningly common, including in America’s hospitals and other health care settings. As leaders of national associations representing hospitals and emergency physicians, we know the intimidation and violence endured by medical professionals every day.

Hospitals 106

Hospitals 106

Pharmacy Times

NOVEMBER 11, 2022

Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.

123

123

STAT

NOVEMBER 11, 2022

The stock price of R1 RCM tanked by roughly 50% this week after the large medical billing and collections company reported an unexpected $30 million loss in the third quarter. R1’s revenue fell in part because health insurers have taken longer to pay claims to R1’s hospital and physician clients, and because it’s been more difficult to collect on patient bills.

Insurance 100

Insurance Hospitals 100

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

NOVEMBER 11, 2022

The European Commission (EC) has granted approval for Sanofi and GSK ’s monovalent, recombinant-protein-based, adjuvanted Covid-19 vaccine, VidPrevtyn Beta, as a booster in adults aged 18 years and above. It is indicated as a booster in people of this age group who were earlier inoculated with a Covid-19 vaccine. The latest development comes after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) provided a positive opinion on vaccine use.

Vaccines 98

Vaccines Immunization FDA 98

STAT

NOVEMBER 11, 2022

As pediatricians, epidemiologists, and professors of public health — as well as mothers — we are often asked if we recommend Covid vaccines for children. Those asking are often skeptical about the benefits and make the point that relatively few kids have died from Covid-19. There’s also some institutional confusion: the American Academy of Pediatrics  and the Centers for Disease Control and Prevention  have urged families to get their children vaccinated, but some

Vaccines 98

Vaccines 98

DiversifyRx

NOVEMBER 11, 2022

Doctor detailing is essential to your pharmacy’s growth and marketing strategy plan. Doctor Detailing Basics. I often refer to doctor visits as dating. You’re dating multiple doctors, and each one has their personality. Some are needy, some like gifts, and some like to be left alone. Therefore, you must adapt the concepts in this article to fit each prescriber and office you are trying to build a rapport.

Independent Pharmacies 98

Independent Pharmacies Insurance 98

STAT

NOVEMBER 11, 2022

Health tech companies that have taken advantage of the possibility to prescribe controlled substances online during the pandemic may soon find their businesses — and their ability to care for patients — in jeopardy.  The public health emergency paved the way for these young companies — whose prescriptions range from ADHD medication to substance use disorder treatment and off-label ketamine for depression — to prescribe medicines without ever seeing a patient in-p

Controlled Substances 98

Controlled Substances Labelling 98

Digital Pharmacist

NOVEMBER 11, 2022

The holiday season is upon us! What a fun time you and your pharmacy team. With all the holiday cheer though, definitely comes stress. Have no fear, we are here to help your pharmacy team prepare and have the best holiday season yet. . Below are 5 simple tips to prepare your pharmacy for the holidays. 1. Outline the Holiday Hours for your Customers.

Communication 98

Communication 98

STAT

NOVEMBER 11, 2022

Christopher Viehbacher, who will start as Biogen’s CEO on Monday , knows that running Biogen may be one of the toughest jobs in the pharmaceutical industry. But he said in an exclusive interview with STAT that after years of working as an investor, and coaching and mentoring other executives, he missed being on the playing field himself. “I’m not the type of guy to go run something that is smoothly running,” Viehbacher said.

98

98

pharmaphorum

NOVEMBER 11, 2022

Elon Musk’s Twitter takeover has been nothing of tumultuous, and that tumult hit home for pharma Thursday when an account impersonating Eli Lilly and Company, taking advantage of lax oversight in the new Twitter Blue program, tweeted “We are excited to announce insulin is free now” Insulin is, of course, not free, especially in the United States where a vial of Humalog, Lilly’s insulin product, can cost upwards of $300 and competing products from Sanofi and Novo Nordisk a

Insurance 98

Insurance 98

STAT

NOVEMBER 11, 2022

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

98

98

Drug Topics

NOVEMBER 11, 2022

According to a study, use is linked to a lower prevalence of age-related macular degeneration in European populations.

98

98

STAT

NOVEMBER 11, 2022

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. We are still setting our agenda, but for the moment, we expect to promenade with our official mascot, have another listening party with Mrs. Pharmalot and attend the latest installment in our “Let’s-see-them-before-they-go” concert series.

Vaccines 98

Vaccines 98

pharmaphorum

NOVEMBER 11, 2022

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he misrepresented the company to investors. Dr Stanley Cohen was sued by Alafi Capital and the Christopher Alafi Family Trust – the only investors in Nuredis – in 2018. The lawsuit claimed he misled them whist persuading them to invest $20 million in the biotech, set up to develop a candidate therapy for neurodegenera

Documentation 97

Documentation FDA 97

Pharmacy Times

NOVEMBER 11, 2022

A new study suggests that 30.5% of US adults lose out on 1 hour or more of sleep due to disturbances.

123

123

pharmaphorum

NOVEMBER 11, 2022

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from ?eyda Atadan Memi?, recently appointed general manager for Takeda UK and Ireland. Here, she discusses her new role, key steps to a successful career in life sciences, and her plans for the future. What inspired you to pursue a career in the life sciences?

97

97

Pharmaceutical Technology

NOVEMBER 11, 2022

AstraZeneca has reported an 11% rise in total revenue to $10.98bn in the third quarter (Q3) 2022 as against $9.87bn in the year-ago quarter. For the quarter ending on 30 September 2022, product sales were reported at $10.59bn from $9.7bn in Q3 last year, indicating a growth of 9%. In the third quarter of 2022, core earnings per share (EPS) were recorded to be $1.67, signifying a 55% increase while reported EPS was $1.06.

FDA 96

FDA 96

STAT

NOVEMBER 11, 2022

Barely a year after he was named head of the Massachusetts Biotechnology Council, former state Senator Joseph Boncore has been ousted and will be replaced with the trade group’s second-highest executive, according to two members of the nonprofit organization’s board of directors. In response to Globe inquiries, MassBio issued a brief statement saying that Boncore “is resigning as CEO to open a consulting practice and will remain an advisor to MassBio on state and federal iss

96

96

Fierce Healthcare

NOVEMBER 11, 2022

CMS seeks to close gaps in health equity data collection as new measures roll out. rking. Fri, 11/11/2022 - 15:32.

121

121

Drug Topics

NOVEMBER 11, 2022

Communication and education are critical to patient confidence in emergency use authorization vaccines.

Vaccines 98

Vaccines Communication 98

Fierce Healthcare

NOVEMBER 11, 2022

HLTH22: Instacart Health partners with ChenMed, Helper Bees, Levels Health to address the root causes of food insecurity. aburky. Fri, 11/11/2022 - 16:56.

98

98

European Pharmaceutical Review

NOVEMBER 11, 2022

Takeda has announced the European Commission’s (EC) authorisation for livtencity TM (maribavir), the first oral UL97 protein kinase inhibitor in adults with post-transplant refractory cytomegalovirus (CMV), who are also resistant to one or more therapies. The drug has been approved for adults who have had haematopoietic stem cell transplants (HSCTs) or solid organ transplants (SOTs) and are resistant to standard antivirals including ganciclovir, valganciclovir, cidofovir and foscarnet.

Labelling 91

Labelling Immunization 91

pharmaphorum

NOVEMBER 11, 2022

The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated and ethnically diverse populations became even more apparent. So has the situation started to improve? Sadly not, says a new report from IQVIA, which looked specifically at the inclusion of Black/African Americans and Hispanics in clinical trials in recent years.

FDA 90

FDA 90